BioXcel Therapeutics, Inc.
BTAI
$1.82
$0.010.55%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/20/2026
-
Nasdaq News: Markets
1/20/2026
-
GuruFocus
1/20/2026
-
The Fly
1/20/2026
-
The Fly
1/20/2026
-
The Fly
1/20/2026
-
Globe Newswire
1/15/2026
-
GuruFocus
1/15/2026
-
Business Wire
1/12/2026
-
The Fly
1/12/2026
-
Globe Newswire
1/7/2026
-
The Fly
1/7/2026
-
Globe Newswire
1/6/2026
-
TipRanks Financial Blog
12/26/2025
-
Ticker Report
12/12/2025
-
GuruFocus
12/11/2025
-
Seeking Alpha: Transcripts
12/11/2025
-
SeekingAlpha
12/8/2025
-
GuruFocus
12/3/2025
-
Globe Newswire
11/21/2025
-
GuruFocus
11/21/2025
-
TipRanks Financial Blog
11/21/2025
-
The Fly
11/13/2025
-
Ticker Report
11/13/2025
-
TipRanks Financial Blog
11/12/2025
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
475 238 6837
Address
555 Long Wharf Drive
New Haven, CT 06511
New Haven, CT 06511
Country
Year Founded
Business Description
Sector
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines...
more